Huntsman DG - Search Results

1

The proteome of clear cell ovarian carcinoma.

Ji JX, Cochrane DR, Negri GL, Colborne S, Spencer Miko SE, Hoang LN, Farnell D, Tessier-Cloutier B, Huvila J, Thompson E, Leung S, Chiu D, Chow C, Ta M, Köbel M, Feil L, Anglesio M, Goode EL, Bolton K, Morin GB, Huntsman DG. Ji JX, et al. Among authors: huntsman dg. J Pathol. 2022 Dec;258(4):325-338. doi: 10.1002/path.6006. Epub 2022 Oct 14. J Pathol. 2022. PMID: 36031730 Free PMC article.

2

Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases.

Huntsman DG, Clement PB, Gilks CB, Scully RE. Huntsman DG, et al. Am J Surg Pathol. 1994 Apr;18(4):364-75. doi: 10.1097/00000478-199404000-00005. Am J Surg Pathol. 1994. PMID: 7511354 Review.

3

Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy.

Huntsman D, Resau JH, Klineberg E, Auersperg N. Huntsman D, et al. Am J Pathol. 1999 Aug;155(2):343-8. doi: 10.1016/S0002-9440(10)65130-9. Am J Pathol. 1999. PMID: 10433927 Free PMC article.

4

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.

Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL. Au NH, et al. Among authors: huntsman dg. J Pathol. 2004 Sep;204(1):101-9. doi: 10.1002/path.1612. J Pathol. 2004. PMID: 15307143

5

Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma.

Lee CH, Huntsman DG, Cheang MC, Parker RL, Brown L, Hoskins P, Miller D, Gilks CB. Lee CH, et al. Among authors: huntsman dg. Int J Gynecol Pathol. 2005 Apr;24(2):147-52. doi: 10.1097/01.pgp.0000152026.39268.57. Int J Gynecol Pathol. 2005. PMID: 15782071

6

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.

Prentice LM, Klausen C, Kalloger S, Köbel M, McKinney S, Santos JL, Kenney C, Mehl E, Gilks CB, Leung P, Swenerton K, Huntsman DG, Aparicio SA. Prentice LM, et al. Among authors: huntsman dg. BMC Med. 2007 Nov 15;5:33. doi: 10.1186/1741-7015-5-33. BMC Med. 2007. PMID: 18005407 Free PMC article.

7

Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.

Crabb SJ, Bajdik CD, Leung S, Speers CH, Kennecke H, Huntsman DG, Gelmon KA. Crabb SJ, et al. Among authors: huntsman dg. Breast Cancer Res. 2008;10(1):R6. doi: 10.1186/bcr1847. Epub 2008 Jan 14. Breast Cancer Res. 2008. PMID: 18194560 Free PMC article. Clinical Trial.

8

Critical molecular abnormalities in high-grade serous carcinoma of the ovary.

Köbel M, Huntsman D, Gilks CB. Köbel M, et al. Expert Rev Mol Med. 2008 Aug 1;10:e22. doi: 10.1017/S146239940800077X. Expert Rev Mol Med. 2008. PMID: 18671886 Review.

9

Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients.

Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, Huntsman D, Berean K. Wong MP, et al. Pathology. 2008 Oct;40(6):611-6. doi: 10.1080/00313020802320614. Pathology. 2008. PMID: 18752129

10

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.

Köbel M, Kalloger SE, Carrick J, Huntsman D, Asad H, Oliva E, Ewanowich CA, Soslow RA, Gilks CB. Köbel M, et al. Am J Surg Pathol. 2009 Jan;33(1):14-21. doi: 10.1097/PAS.0b013e3181788546. Am J Surg Pathol. 2009. PMID: 18830127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page